Tumor necrosis factor alpha inhibitors and reactivation of tuberculosis Source: Eur Respir J 2007; 30: Suppl. 51, 281s Year: 2007
Activation and localization of transcription factor, nuclear factor-κB (NF-κB), in bronchiectasis in vivo Source: Eur Respir J 2001; 18: Suppl. 33, 367s Year: 2001
Investigational therapeutics targeting the IL-4/IL-13/STAT-6 pathway for the treatment of asthma Source: Eur Respir Rev 2009; 19: 46-54 Year: 2010
Interferon-gamma downregulates the major group rhinovirus receptor intercellular adhesion molecule 1 via a signal transducer and activator of transcription-1-dependent mechanisms Source: Eur Respir J 2001; 18: Suppl. 33, 475s Year: 2001
Transcription factor activation and mitogenic synergism in airway smooth muscle cells Source: Eur Respir J 2003; 21: 759-769 Year: 2003
Intermittent hypoxia activates the Interleukin (IL)-1ß and nuclear factor (NF)?B signaling pathway in primary murine macrophages Source: International Congress 2019 – Insights into the pathophysiology of sleep-disordered breathing Year: 2019
TLR9- and Src-dependent expression of Krueppel-like factor 4 controls interleukin-10 expression in pneumonia Source: Eur Respir J 2013; 41: 384-391 Year: 2013
LATE-BREAKING ABSTRACT: RV568, a narrow spectrum kinase inhibitor (NSKI), inhibits virus induced nasal interleukin-8 (IL8) in the human viral challenge model where healthy adult male volunteers were experimentally inoculated with live respiratory syncytial virus Source: Annual Congress 2013 –Hot topics on airway diseases: new horizons in treatment Year: 2013
Amplified virus infection in a transforming growth factor-beta (TGFB) transgenic mouse model of inflammatory lung disease Source: International Congress 2018 – Mechanisms of respiratory infection Year: 2018
Transforming growth factor beta (TGF-β) augments rhinovirus (RV) replication in primary bronchial epithelial cells (pbecs) through modulation of the innate immune response Source: Annual Congress 2009 - Viruses and respiratory infections: prevalence and mechanisms of infection Year: 2009
Infection of human peribronchial gland cells (PBGC) with respiratory syncytial virus (RSV) shows a interaction of RSV with the nuclear factor (NF) κB-complex Source: Eur Respir J 2001; 18: Suppl. 33, 305s Year: 2001
The natural anticoagulant activated protein C inhibits the expression of platelet-derived growth factor in the lung Source: Eur Respir J 2002; 20: Suppl. 38, 571s Year: 2002
The risk of tuberculosis related to tumour necrosis factor antagonist therapies: a TBNET consensus statement Source: Eur Respir J 2010; 36: 1185-1206 Year: 2010
Tumor necrosis factor and pulmonary gas transfer in common variable immunodeficiency Source: Eur Respir J 2005; 26: Suppl. 49, 686s Year: 2005
Syndecan-1 attenuates lung injury during influenza infection by activating survival signals via c-Met Source: Lung Science Conference 2015 Year: 2015
Altered expression of the Smad signalling pathway: implications for COPD pathogenesis Source: Eur Respir J 2006; 28: 533-541 Year: 2006
Human respiratory syncytial virus infection in vivo and in vitro induces expression of the B cell differentiation factor BAFF Source: Annual Congress 2011 - Viral respiratory infections in children: causes and consequences Year: 2011
Immunokinetics in severe pneumonia due to influenza virus and bacteria coinfection in mice Source: Eur Respir J 2004; 24: 143-149 Year: 2004
Study of tumor necrosis factor family genes in two phenotypes of COPD Source: Eur Respir J 2002; 20: Suppl. 38, 87s Year: 2002